Evidence map›Paper›PMID 38557489›Full record

ArticleThe Journal of clinical investigation2024

OCaR1 endows exocytic vesicles with autoregulatory competence by preventing uncontrolled Ca2+ release, exocytosis, and pancreatic tissue damage.

Volodymyr Tsvilovskyy, Roger Ottenheijm, Ulrich Kriebs, Aline Schütz, Kalliope Nina Diakopoulos, Archana Jha, Wolfgang Bildl, Angela Wirth, Julia Böck, Dawid Jaślan and 30 more

Open access · goldAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
5.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Allosteric switching of CaThe EMBO journal · 2026
    Article
  3. TPC1-dependent control of endosomal pH and transferrin uptake determines cellular iron status.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. TMEM63A, associated with hypomyelinating leukodystrophies, is an evolutionarily conserved regulator of myelination.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  9. Article
  10. Review
  11. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

40 authors at 13 institutions in 4 countries.

Volodymyr TsvilovskyyInstitute of Pharmacology, Heidelberg University, Heidelberg, Germany.
Roger OttenheijmInstitute of Pharmacology, Heidelberg University, Heidelberg, Germany.
Ulrich KriebsInstitute of Pharmacology, Heidelberg University, Heidelberg, Germany.
Aline SchützInstitute of Pharmacology, Heidelberg University, Heidelberg, Germany.
Kalliope Nina DiakopoulosComprehensive Cancer Center München, Chair for Tumor Metabolism, Klinikum rechts der Isar, Technical University of Munich, School of Medicine and Health, Munich, Bavaria, Germany
Archana JhaEpithelial Signaling and Transport Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, USA.
Wolfgang BildlInstitute for Physiology, University of Freiburg, Freiburg, Germany.
Angela WirthInstitute of Pharmacology, Heidelberg University, Heidelberg, Germany.
Julia BöckWalther-Straub-Institut für Pharmakologie und Toxikologie, Ludwig-Maximilians-Universität München, Munich, Germany.
Dawid JaślanWalther-Straub-Institut für Pharmakologie und Toxikologie, Ludwig-Maximilians-Universität München, Munich, Germany.
Irene FerroWalther-Straub-Institut für Pharmakologie und Toxikologie, Ludwig-Maximilians-Universität München, Munich, Germany.
Francisco J TabernerInstitute of Pharmacology, Heidelberg University, Heidelberg, Germany.
Olga KalininaHelmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI), Saarbrücken, Germany.
Staffan HildebrandInstitut für Pharmakologie und Toxikologie, Universität Bonn, Bonn, Germany.
Ulrich WissenbachExperimental and Clinical Pharmacology and Toxicology, Center for Molecular Signaling (PZMS), Saarland University, Homburg, Germany.
Petra WeissgerberExperimental and Clinical Pharmacology and Toxicology, Center for Molecular Signaling (PZMS), Saarland University, Homburg, Germany.
Dominik VogtInstitute of Pharmacology, Heidelberg University, Heidelberg, Germany.
Carola EberhagenInstitute of Molecular Toxicology and Pharmacology, Helmholtz Center Munich, German Research Center for Environmental Health, Neuherberg, Germany.
Stefanie MannebachExperimental and Clinical Pharmacology and Toxicology, Center for Molecular Signaling (PZMS), Saarland University, Homburg, Germany.
Michael BerlinInstitute of Pharmacology, Heidelberg University, Heidelberg, Germany.
Vladimir KuryshevInstitute of Pharmacology, Heidelberg University, Heidelberg, Germany.
Dagmar SchumacherInstitute of Pharmacology, Heidelberg University, Heidelberg, Germany.
Koenraad PhilippaertInstitute of Pharmacology, Heidelberg University, Heidelberg, Germany.
Juan E Camacho-LondoñoInstitute of Pharmacology, Heidelberg University, Heidelberg, Germany.
Ilka MatharInstitute of Pharmacology, Heidelberg University, Heidelberg, Germany.
Christoph DieterichUniversity Hospital Heidelberg, Department of Medicine III: Cardiology, Angiology and Pneumology, Heidelberg, Germany.
Norbert KlugbauerInstitut für Experimentelle und Klinische Pharmakologie und Toxikologie, Fakultät für Medizin, Albert-Ludwigs-Universität Freiburg, Freiburg, Germany.
Martin BielCenter for Integrated Protein Science Munich (CIPS-M) and Center for Drug Research, Department of Pharmacy, Ludwig-Maximilians-Universität München, and DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany.
Christian Wahl-SchottWalter Brendel Centre of Experimental Medicine, Biomedical Center, Institute of Cardiovascular Physiology and Pathophysiology, Medical Faculty, Ludwig-Maximilians-Universität München, Planegg-Martinsried, Germany.
Peter LippInstitute for Molecular Cell Biology, Center for Molecular Signaling (PZMS), Universität des Saarlandes, Homburg, Germany.
Veit FlockerziExperimental and Clinical Pharmacology and Toxicology, Center for Molecular Signaling (PZMS), Saarland University, Homburg, Germany.
Hans ZischkaInstitute of Molecular Toxicology and Pharmacology, Helmholtz Center Munich, German Research Center for Environmental Health, Neuherberg, Germany.
Hana AlgülComprehensive Cancer Center München, Chair for Tumor Metabolism, Klinikum rechts der Isar, Technical University of Munich, School of Medicine and Health, Munich, Bavaria, Germany
Stefan G LechnerInstitute of Pharmacology, Heidelberg University, Heidelberg, Germany.
Marina LesinaComprehensive Cancer Center München, Chair for Tumor Metabolism, Klinikum rechts der Isar, Technical University of Munich, School of Medicine and Health, Munich, Bavaria, Germany
Christian GrimmWalther-Straub-Institut für Pharmakologie und Toxikologie, Ludwig-Maximilians-Universität München, Munich, Germany.
Bernd FaklerInstitute for Physiology, University of Freiburg, Freiburg, Germany.
Uwe SchulteInstitute for Physiology, University of Freiburg, Freiburg, Germany.
Shmuel MuallemEpithelial Signaling and Transport Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, USA.
Marc FreichelInstitute of Pharmacology, Heidelberg University, Heidelberg, Germany.
Heidelberg University · DESaarland University · DEUniversity of Freiburg · DELudwig-Maximilians-Universität München · DETUM Klinikum · DEHelmholtz Zentrum München · DENational Institute of Dental and Craniofacial Research · USCenter for Integrated Protein Science Munich · DECentre of Experimental Medicine of the Slovak Academy of Sciences · SKConsejo Superior de Investigaciones Científicas · ESFraunhofer Institute for Translational Medicine and Pharmacology · DEHelmholtz Centre for Infection Research · DEUniversity of Bonn · DE

Funding

Ca2+ signaling and HCO3- secretion by exocrine glandsZIADE000735 · NIDCR · NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH · PI MUALLEM, SHMUEL · 2010 to 2025
$43.1M
6 · The paper itself

Abstract

Regulated exocytosis is initiated by increased Ca2+ concentrations in close spatial proximity to secretory granules, which is effectively prevented when the cell is at rest. Here we showed that exocytosis of zymogen granules in acinar cells was driven by Ca2+ directly released from acidic Ca2+ stores including secretory granules through NAADP-activated two-pore channels (TPCs). We identified OCaR1 (encoded by Tmem63a) as an organellar Ca2+ regulator protein integral to the membrane of secretory granules that controlled Ca2+ release via inhibition of TPC1 and TPC2 currents. Deletion of OCaR1 led to extensive Ca2+ release from NAADP-responsive granules under basal conditions as well as upon stimulation of GPCR receptors. Moreover, OCaR1 deletion exacerbated the disease phenotype in murine models of severe and chronic pancreatitis. Our findings showed OCaR1 as a gatekeeper of Ca2+ release that endows NAADP-sensitive secretory granules with an autoregulatory mechanism preventing uncontrolled exocytosis and pancreatic tissue damage.

Indexed as

CalciumCalcium ChannelsAnimalsExocytosisMicePancreasSecretory VesiclesCalciumCalcium ChannelsCalcium signalingCell biologyIon channelsLysosomes

Identifiers

PMID38557489
PMCPMC10977991
OpenAlexW4393356396

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.